The future of population strategies in prevention

Abstract

Get full access to this article

View all access options for this article.

References

1. Rose G. The strategy of preventive medicine. Oxford: Oxford University Press, 1992.

2. Oliver M , Poole-Wilson P , Shepherd J , Tikkanen M. Lower patients' cholesterol now. Br Med J 1995; 310: 1280–1.

3. Davey Smith G , Egger M.

Who benefits from medical interventions?

Br Med J 1994; 308: 72–4.

4. Buiatti E. Intervention trials of cancer prevention: results and new programs. IARC: Technical report no. 18. Lyon: IARC, 1994.

5. Topo P , Koster A , Holte A , et al . Trends in the use of climacteric and postclimacteric hormones in Nordic countries. Maturitas 1995; 22: 89–95.

6. Hemminki E , Topo P , Malin M , Kangas I. Physicians' views on hormone therapy around and after menopause. Maturitas 1993; 16: 163–73.

7. Hemminki E , Sihvo S. A review of postmenopausal hormone therapy recommendations: Potential for selection bias. Obstet Gynecol 1993; 82: 1021–8.

8. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group . The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029–35.